+
Site Tour

Search

Showing 1 - 10 of 533 results.

  • Connext

    Therapies Valvular Diseases Mitral Valve Disease Aortic Valve Disease Tricuspid Valvle Disease Paravalvular Leak
  • Launch Video

    WELCOME TO MY-CONNEXT.COM
  • Amplatzer Piccolo™ Occluder

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER PICCOLO™ OCCLUDER: FOR PDA CLOSURE IN THE SMALLEST PATIENTS INDUSTRY-LEADING
  • Guidelines

    Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). Interventi
  • Overview

    Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a ca
  • Transcatheter Repair

    Transcatheter edge-to-edge repair (TEER) is a minimally invasive option: Overall, many patients in need of valve reconstruction or replacement do not undergo surgery because of high perioperative ris
  • ESC GUIDELINES 2025 – ABBOTT AT ESC

    ESC Congress 2025 Shaping the Future of Structural Heart Therapies ESC Congress 2025 delivered powerful momentum in TEER and TAVI, with key updates that are now shaping clinical practice. Dive int
  • Overview

    WATCH HOW MITRACLIP™ TEER TRANSFORMED LUCA'S LIFE LEARN MORE: DOWNLOAD FLYER LEARN MORE: PCR LV 2025 Symposium ESC/EACTS 2025 GUIDELINES Imaging Webinars 2025 EuroPCR Symposiu
  • Overview

    TREATMENT RANGE 4 MM TO 40 MM No other ASD closure device on the market today can match ASO’s wide range of device sizes.
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion WATCH ON DEMAND: IMAGING WEBINARS 2025  LAAO SUMMIT 2025 LEARN MORE:

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline